Skip to main content
OpenTrials
Completed

NCT Number: NCT07126522

Virtual Support Platform (HERCaRE Application) for the Improvement of Survivorship Among Black Breast Cancer Survivors

This clinical trial studies how well a virtual support platform, the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) application (app), works in improving survivorship among Black survivors of breast cancer. The HERCaRE platform is a mobile-friendly app that includes culturally tailored educational materials, interactive content, and health equity resources to help patients better understand and manage survivorship after breast cancer treatment. This trial may help improve how digital health interventions can enhance survivorship support and access to resources.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic in Florida

Jacksonville, Florida, 32224-9980, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 and older
  • Self-identified Black women with a history of breast cancer
  • "Self-identified Black woman" refers to individuals who personally identify as a Black or African American woman, inclusive of cisgender women from diverse cultural backgrounds. This will be confirmed during a verbal eligibility screening conducted prior to enrollment
  • Completed active breast cancer treatment (e.g., surgery, chemotherapy, or radiation) at least one month prior to enrollment; survivors receiving long-term hormonal therapy are also eligible
  • Reside within the Mayo Clinic Florida catchment area
  • Have access to a smartphone or willingness to use alternative access points
  • "Alternative access points" refer to non-clinical settings through which participants may be made aware of the study, including support groups, community health events, churches, and partner organizations that engage with breast cancer survivors outside of the traditional healthcare setting

Exclusion criteria

  • Individuals without a history of breast cancer
  • Those unable to provide verbal consent
  • Individuals who lack the ability to engage with digital platforms, as determined during the screening process via brief questions assessing comfort and experience with mobile technology. Participants must be able to open the app, read content, and complete survey independently. iPads will be available for participants who do not have their own mobile device

Treatment and study plan

Discussion

Other

Ancillary studies

Other names: Discuss

Internet-Based Intervention

Other

Use the HERCaRE app

interview

Other

Ancillary studies

Survey Administration

Other

Ancillary studies

Primary outcomes

  1. Survivorship engagement - login

    Time frame: Up to 6 weeks

    Assessed by active use of the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) platform, defined as number of logins per participant.

  2. Survivorship engagement - time

    Time frame: Up to 6 weeks

    Assessed by the length of time each participant spent using the HERCaRE platform.

  3. Survivorship engagement - self-report

    Time frame: Up to 6 weeks

    Assessed by self-reported actions such as initiating conversations with providers or accessing survivorship resources. Information will be obtained through semi-structured interviews.

  4. Adherence to follow-up care

    Time frame: Up to 6 weeks

    Assessed by participant self-reported scheduling or completion of appointments (e.g., mammograms, primary care physician visits). Information will be obtained through semi-structured interviews.

Secondary outcomes

  1. Participant satisfaction - HERCaRE Final Survey

    Time frame: Up to 6 weeks

    Will be assessed by 5 question from a 9-question HERCaRE Final Survey. Three questions are answered on a 5-point scale (strongly agree, agree, neutral, disagree, strongly disagree), and two questions are open-ended/free text.

  2. Perceived usability - HERCaRE Final Survey

    Time frame: Up to 6 weeks

    Will be assessed by a 4 question of a 9-question HERCaRE Final Survey. Two questions are multiple choice (e.g., Yes, No, Not sure) Once is related to likelihood of taking follow-up actions such as "schedule and attend a follow-up appointment" or "ask more questions during my next visit." The final question is an open-ended/free text question related to any difficulties using the app or competing activities.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Advancing Survivorship Support Through Virtual Health Equity Resources for Breast Cancer Responsive Education (HERCaRE)

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 17, 2025
Registry last updated
Mar 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.